Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about JNJ

Recent news which mentions JNJ

...

11 12 13 14 15 16 17 18 19

...

Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

October 14, 2024

This Is What Whales Are Betting On Johnson & Johnson

October 14, 2024

More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug

October 14, 2024

Johnson & Johnson Preps For Q3 Earnings As MedTech Expands, But Stock Sends Mixed Signals

October 14, 2024

Columbus Day: Is Stock Market Open Today?

October 14, 2024

All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year

October 13, 2024

Market Whales and Their Recent Bets on JNJ Options

October 11, 2024

World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice

October 11, 2024

What Analysts Are Saying About Johnson & Johnson Stock

October 10, 2024

Insights Into Johnson & Johnson's Performance Versus Peers In Pharmaceuticals Sector

October 10, 2024

1 Vanguard Index Fund Could Turn $500 Per Month Into a $968,400 Portfolio That Pays $16,000 in Annual Dividend Income

October 09, 2024

What To Expect When Johnson & Johnson Reports Q3 Earnings Next Week?

October 08, 2024

Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization

October 04, 2024

2 Smart Income Stocks to Buy Right Now

October 04, 2024

Johnson & Johnson's Options: A Look at What the Big Money is Thinking

October 02, 2024

Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug

October 02, 2024

Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients

September 30, 2024

2 Excellent Dividend Stocks to Buy With Less Than $200

September 28, 2024

Johnson & Johnson Reports Updated Data From Two Early-Stage Multiple Myeloma Studies Of Talvey Combo Treatment

September 27, 2024

In-Depth Analysis: Johnson & Johnson Versus Competitors In Pharmaceuticals Industry

September 26, 2024

Why Masimo Stock Crushed the Market Today

September 25, 2024

Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff

September 25, 2024

2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off

September 25, 2024

10 Health Care Stocks With Whale Alerts In Today's Session

September 23, 2024

Is Johnson & Johnson Stock a Buy?

September 21, 2024

Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients

September 20, 2024

Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease

September 20, 2024

The Latest Analyst Ratings For Johnson & Johnson

September 19, 2024

2 Vanguard Index Funds Could Turn $400 Per Month Into $16,800 in Annual Dividend Income by Retirement

September 19, 2024

Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug

September 18, 2024

...

11 12 13 14 15 16 17 18 19

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.